Related Experiment Videos
Recurrent or persistent thyroid cancer of follicular cell origin
M Duren1, Q Y Duh, A E Siperstein
1Department of Surgery, University of California, San Francisco/Mount Zion Medical Center, San Francisco, CA 94143-1674, USA.
Current Treatment Options in Oncology
|June 12, 2002
Summary
The extent of initial surgery for differentiated thyroid cancer does not significantly impact long-term survival. Reoperation may benefit patients with persistent or recurrent disease, improving outcomes for thyroid cancer patients.
Area of Science:
- Oncology
- Endocrinology
- Surgical Oncology
Background:
- Differentiated thyroid cancer (DTC) of follicular cell origin generally has a favorable prognosis.
- The impact of initial surgical extent on DTC outcomes is debated.
- The benefit of reoperation for persistent or recurrent DTC requires clarification.
Purpose of the Study:
- To investigate the influence of initial surgical treatment extent on tumor-free and overall survival in DTC patients.
- To evaluate the efficacy of reoperation in managing persistent or recurrent DTC.
Main Methods:
- Retrospective analysis of DTC patient data.
- Comparative survival analysis based on initial surgical extent.
- Assessment of outcomes following reoperation for recurrent/persistent disease.
Main Results:
- Initial surgical extent did not demonstrate a significant correlation with tumor-free survival or overall survival.
- Patients undergoing reoperation for persistent or recurrent DTC showed improved outcomes.
Conclusions:
- The extent of initial surgery is not a primary determinant of long-term prognosis in DTC.
- Reoperation is a beneficial therapeutic option for patients with persistent or recurrent differentiated thyroid cancer.